Pear Adds Spanish Version Of Its Addiction Therapy PDTs
Availability of Spanish-language prescription digital therapeutics for the treatment of substance use disorder and opioid use disorder will address important health equity and health care disparities, according to Pear.
You may also be interested in...
Medtech Insight spoke to Pear Therapeutics CEO Corey McMann about the emerging digital therapeutics market and his company’s future now that it has the first PDT covered by Medicaid.
Pear Therapeutics acquired a digital therapeutic for depression from Waypoint Health and licensed an Internet-based cognitive behavior therapy program for residual symptoms of depression from a psychologist in Sweden.
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.